Linette et al. 13described a lethal 'off‐target' cardiovascular toxicity in patients with malignant melanoma treated with melanoma‐associated antigen 3 (MAGE‐A3)‐specific T‐cell receptor (TCR) T cells. The gene discussed is MAGEA3; the disease is melanoma.